AKEBIA THERAPEUTICS INCAKEBIA THERAPEUTICS INCAKEBIA THERAPEUTICS INC

AKEBIA THERAPEUTICS INC

No trades
See on Supercharts

Price target

4.640.00 0.00%
The 3 analysts offering 1 year price forecasts for AX9 have a max estimate of — and a min estimate of —.

Analyst rating

Based on 3 analysts giving stock ratings to AX9 in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

AX9 EPS for the last quarter is −0.08 EUR despite the estimation of −0.07 EUR. In the next quarter EPS is expected to reach −0.05 EUR. Track more of AKEBIA THERAPEUTICS INC financials and stay on top of what is up with the company.
In the next quarter AKEBIA THERAPEUTICS INC revenue is expected to reach ‪46.07 M‬ EUR. Check out AKEBIA THERAPEUTICS INC revenue and earnings and make informed decisions.
According to analysts, AX9 price target is 4.64 EUR with a max estimate of 5.57 EUR and a min estimate of 3.72 EUR. Check if this forecast comes true in a year, meanwhile watch AKEBIA THERAPEUTICS INC stock price chart and keep track of the current situation with AX9 news and stock market news.